Marco Vincenzo Lenti

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

50 publications 2024 – 2026 ORCID

What does Marco Vincenzo Lenti research?

Dr. Lenti studies various conditions affecting the gastrointestinal tract, including small bowel adenocarcinoma (SBA), autoimmune gastritis (AIG), and inflammatory bowel diseases such as ulcerative colitis. He investigates how these diseases evolve, their related cancer risks, and factors influencing treatment outcomes. Through his research, he identifies different disease subtypes and potential treatment options, aiming to improve diagnosis, treatment plans, and overall patient care.

Key findings

  • In a study of small bowel adenocarcinoma, 20% of metastatic tumors displayed new mutations, underscoring the need for retesting within the same patient.
  • Among 1,240 autoimmun gastritis patients, 2.9% developed gastric adenocarcinomas and 10.6% developed neuroendocrine tumors, with age and gastrin levels predicting higher risks.
  • Of 379 ulcerative colitis patients studied, 90.5% achieved adequate bowel preparation for colonoscopy, with the 1L-PEG-ASC method outperforming the 2L-PEG method on cleanliness scores (8 vs. 6 out of 9).
  • B-cell lymphomas had a median survival of 56 months compared to just 12 months for T-cell lymphomas, indicating a markedly better prognosis for B-cell patients.
  • In patients with celiac disease, only 30% of T-cell lymphoma patients responded to a gluten-free diet, while nearly all patients with small bowel adenocarcinoma benefited from it.

Frequently asked questions

Does Dr. Lenti study small bowel cancer?
Yes, Dr. Lenti conducts research on small bowel adenocarcinoma and its genetic variations to improve treatment options.
What is autoimmune gastritis and does Dr. Lenti research it?
Autoimmune gastritis is an inflammation of the stomach lining caused by the immune system attacking its cells. Dr. Lenti's research includes studying its cancer risks and patient profiles.
How does Dr. Lenti's work help patients with inflammatory bowel disease?
His studies identify factors affecting treatment adherence and improve bowel preparation methods for procedures like colonoscopy, enhancing patient care.
Are there different types of celiac disease?
Yes, Dr. Lenti’s research has identified distinct subgroups of celiac disease patients based on their symptoms, which can lead to better diagnoses and tailored treatments.
Does exposure to pollen affect gastrointestinal conditions?
Yes, Dr. Lenti found that patients with irritable bowel syndrome who are allergic to grass pollen may experience worse symptoms during pollen season.

Publications in plain English

Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study.

2026

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Maniero D, Ghisa M, Bruschi A, Lorenzon G, Bertin L +27 more

Plain English
This study looked at how well orodispersible budesonide (BOTs) works for adults with eosinophilic esophagitis (EoE) in real-life situations. Researchers found that after 12 weeks of treatment, 84% of patients achieved deep remission, meaning their symptoms and inflammation significantly improved, and by one year, 78% of those who continued treatment maintained this success. The findings are important because they demonstrate that BOTs are effective and safe for managing EoE, with only mild side effects reported in 12% of patients. Who this helps: This helps adult patients with eosinophilic esophagitis seeking effective treatment options.

PubMed

Autoimmune gastritis: Diagnosis, clinical management and natural history. A position paper by the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO).

2026

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Lahner E, Lenti MV, Massironi S, Zingone F, Miceli E +6 more

Plain English
This study focused on autoimmune atrophic gastritis (AAG), a condition where the immune system attacks the stomach lining, leading to problems like low stomach acid and difficulty absorbing important nutrients. The authors noted that many patients are often misdiagnosed or experience delays in their diagnosis, which can lead to serious health issues, including anemia and an increased risk of stomach cancer. Understanding AAG better is crucial for prompt diagnosis and better treatment, which can improve patients' health and reduce related healthcare costs. Who this helps: This helps patients with autoimmune gastritis and their doctors.

PubMed

Editorial: The Hidden Burden-Stigmatisation in Inflammatory Bowel Disease.

2026

Alimentary pharmacology & therapeutics

Lenti MV, Santacroce G, Di Sabatino A

PubMed

DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.

2026

Gastrointestinal endoscopy

Scalvini D, Maimaris S, Cappellini A, Lusetti F, Delogu C +12 more

Plain English
The study looked at whether an additional procedure called terminal ileal intubation (TII) is useful during colonoscopies for people who don’t have any symptoms, specifically for colorectal cancer screening or after polyp removal. Researchers reviewed data from 11 studies involving over 25,000 patients and found that TII only detected important issues in 0.28% of cases and Crohn's disease in just 0.1% of cases, meaning it doesn’t significantly improve the chances of finding serious health problems. This matters because it suggests that doing TII for these patients is unnecessary and may just add time to the procedure without providing real benefits. Who this helps: This helps doctors and patients by clarifying which procedures are necessary during colonoscopy.

PubMed

Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.

2026

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Cavagna L, Lenti MV, Cucinella L, Bottazzi F, Di Sabatino A +1 more

Plain English
This study looked at how different stages of a woman's life, such as menstruation, pregnancy, and menopause, affect autoimmune diseases (conditions where the immune system attacks the body). The researchers found that these reproductive stages can change how autoimmune diseases develop and worsen, while these diseases can also affect a woman’s fertility and pregnancy experiences. The findings emphasize the need for better detection, care strategies, and support for women with autoimmune diseases at all stages of life to improve health outcomes for both mothers and their children. Who this helps: This helps women with autoimmune diseases, healthcare providers, and their families.

PubMed

Author's reply: "Anti-parietal cell antibodies are more prevalent and clinically relevant in autoimmune endocrine diseases: Comment on the ARIOSO position paper".

2026

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Lahner E, Lenti MV, Massironi S, Miceli E, Della Bella C +4 more

PubMed

Interlesional Genomic Heterogeneity in Small Bowel Adenocarcinoma: Evidence from Matched Primary and Peritoneal Metastatic Lesions.

2026

Clinics and research in hepatology and gastroenterology

Vanoli A, Parente P, De Lisi G, Travaglino E, Antoci F +13 more

Plain English
This study looked at how cancer can change over time by comparing the genetic makeup of small bowel adenocarcinoma (SBA) tumors and their spread to the peritoneum (the lining of the abdominal cavity). Researchers found that in four cases, the cancer in the peritoneum was genetically identical to the primary tumors, while in one case, the metastatic tumor developed a new mutation over time. This highlights that cancers can vary even within the same patient, stressing the importance of testing metastases again for better treatment decisions. Who this helps: Patients with small bowel adenocarcinoma and their doctors.

PubMed

Clinical features and survival in primary intestinal lymphomas: A multicentre study.

2026

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Aronico N, Santacroce G, Lucioni M, Lenti MV, Bianchi PI +13 more

Plain English
This study looked at two rare types of intestinal lymphomas, B-cell and T-cell, to understand their clinical features and survival rates. The researchers found that B-cell lymphomas are usually diagnosed earlier and patients live much longer, with a median follow-up showing a survival rate more than five times better than T-cell lymphomas (56 months for B-cell compared to only 12 months for T-cell). It’s important because understanding these differences can help doctors choose better treatments and care plans for patients. Who this helps: This helps patients with intestinal lymphomas and their doctors.

PubMed

Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.

2026

Diagnostics (Basel, Switzerland)

Scalvini D, Maimaris S, Stasi E, Valvano M, Brinch D +21 more

Plain English
This study looked at how well patients with ulcerative colitis (UC) prepare their bowels for colonoscopies when their disease is under control, and compared two different bowel prep methods. Among 379 patients, 90.5% had adequate bowel preparation, but those using the 1L-PEG-ASC method scored better on cleanliness (8 out of 9) compared to those using 2L-PEG (6 out of 9) and had a higher exam completion rate (99.5% vs. 95.7%). This is important because it shows that even without active disease, good bowel prep is essential for effective cancer screenings, highlighting the benefits of using the 1L-PEG-ASC method for better results. Who this helps: Patients with ulcerative colitis needing colonoscopies.

PubMed

Novel insights into autoimmune gastritis: clinical profile and gastric neoplastic risk from an international multicentre study.

2026

Gut

Lenti MV, Miceli E, Soykan I, Riquelme A, Latorre G +40 more

Plain English
This study looked at autoimmune gastritis (AIG) in 1,240 patients from different parts of the world, focusing on their health profiles and the risk of developing gastric cancer and neuroendocrine tumors. They found that 2.9% of patients developed gastric adenocarcinomas, while 10.6% developed neuroendocrine tumors; certain factors like being over 65 years old or having high gastrin levels significantly increased cancer risk. Understanding these regional differences in AIG and its risks can help doctors create better follow-up plans for patients. Who this helps: This benefits patients with autoimmune gastritis and their healthcare providers.

PubMed

Factors associated to multiple chronic conditions in internal medicine patients.

2025

European journal of internal medicine

Lenti MV, Frenna C, Brera AS, Klersy C, Corazza GR +1 more

PubMed

LINE-1 hypomethylation characterizes the inflammatory response in coeliac disease associated-intestinal mucosa and small bowel adenocarcinomas.

2025

The Journal of pathology

Libera L, Vanoli A, Sahnane N, Adnan M, Guerini C +7 more

Plain English
This study looked at how the loss of a type of DNA methylation called LINE-1 hypomethylation relates to the inflammatory response in patients with coeliac disease and those with small bowel cancer. Researchers found that patients with untreated coeliac disease had significantly decreased LINE-1 methylation, and this was also true for those with small bowel adenocarcinomas linked to coeliac disease. However, patients who followed a strict gluten-free diet showed a return to normal methylation levels, indicating a possible way to reverse the problem. Who this helps: This benefits patients with coeliac disease, particularly those at risk of developing small bowel cancer.

PubMed

Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine.

2025

Gut

Santacroce G, Rossi CM, Lenti MV, Ghosh S, Iacucci M +1 more

Plain English
This study focused on eosinophilic esophagitis (EoE), a condition where the esophagus becomes inflamed and damaged due to immune reactions, leading to difficulties in swallowing. Researchers found that ongoing tissue injury and repair processes contribute to worsening symptoms and complications in patients. Current treatments are limited, but new technologies and approaches, including the use of artificial intelligence, are helping to understand the disease better and could lead to more tailored treatments in the future. Who this helps: This benefits patients with eosinophilic esophagitis by potentially improving their treatment options.

PubMed

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease.

2025

Journal of Crohn's & colitis

Buoso E, Masi M, Limosani RV, Fagiani F, Oliviero C +14 more

Plain English
This study looked at the role of a protein called RACK1 in inflammatory bowel disease (IBD) and how it affects the lining of the intestines. Researchers found that RACK1 levels were significantly lower in IBD patients, particularly those with ulcerative colitis, which contributed to damage in the intestinal barrier. They discovered that targeting this GILZ/RACK1 pathway could lead to new treatments, especially for patients who do not respond well to current therapies like dexamethasone. Who this helps: This helps patients with inflammatory bowel disease, particularly those struggling to find effective treatments.

PubMed

Eosinophilic oesophagitis in adults: from symptoms to therapeutic options.

2025

Internal and emergency medicine

Rossi CM, Lenti MV, Santacroce G, Merli S, Vanoli A +1 more

Plain English
This study looked at eosinophilic oesophagitis (EoE), a long-lasting condition that mainly affects young men with allergies and can cause serious problems like difficulty swallowing and scarring of the esophagus. Researchers found that with new treatments, such as a specific medication called budesonide and a biological drug named dupilumab, patients can manage their symptoms more effectively. Recognizing the signs of EoE early and referring patients to specialists is crucial for improving care and outcomes for those affected. Who this helps: This helps patients suffering from eosinophilic oesophagitis and their healthcare providers.

PubMed

Long-term Prognosis of Nonceliac Enteropathies and a Score to Identify Patients With Poor Outcomes: A 30-year Multicenter Longitudinal Study.

2025

The American journal of gastroenterology

Schiepatti A, Maimaris S, Scalvini D, Raju SA, Ingham KE +18 more

Plain English
This study looked at the long-term health outcomes of patients with nonceliac enteropathies (NCEs), which are digestive disorders not related to celiac disease, over a period of 30 years. Researchers found that 10 years after diagnosis, about 74% of patients were still alive, but mortality rates were significantly higher for these patients compared to the general population, with a mortality rate about three times higher. They created a scoring system to identify patients at higher risk of serious health issues, allowing for better monitoring and personalized treatment plans. Who this helps: This research benefits patients with nonceliac enteropathies and their doctors by providing insights for better management and care.

PubMed

Coeliac disease and chronic liver disease: a double-face issue.

2025

The Lancet regional health. Europe

Lenti MV, Bianchi PI, Di Sabatino A

PubMed

Impairment of Innate Immunity and Depletion of Vaccine-Induced Memory B and T Cells in the Absence of the Spleen.

2025

American journal of hematology

Bordoni V, Cinicola BL, Piano Mortari E, Castilletti C, Guarracino F +17 more

Plain English
This study looked at how the absence of the spleen, either from surgery or being born without one, affects the immune system in both adults and children. Researchers found that adults without a spleen had significantly fewer memory B and T cells a year after vaccination, even though they had normal antibody levels. This decline in immune memory can increase the risk of infections and shows that the spleen plays a crucial role in keeping our immune systems functioning well. Who this helps: This research benefits doctors and patients who have had their spleens removed or were born without one, helping them understand their increased infection risks and potential need for additional vaccinations.

PubMed

Meta-Analysis: Pregnancies With Inflammatory Bowel Disease Complicated by Intrahepatic Cholestasis of Pregnancy.

2025

Alimentary pharmacology & therapeutics

Joudaki S, Oladipupo O, Carbery I, Lenti MV, Selinger CP

Plain English
This research looked at how common intrahepatic cholestasis of pregnancy (ICP) is among pregnant women with inflammatory bowel disease (IBD) and how the medication thiopurine affects this risk. The study found that about 3% of the 1,603 pregnancies studied had ICP, which is significantly higher than in the general population, with women on thiopurines having an even greater risk (over six times more likely). This matters because understanding these risks can help doctors better monitor and care for pregnant patients with IBD, especially those taking thiopurine medications. Who this helps: Patients with inflammatory bowel disease who are pregnant.

PubMed

Undiagnosed celiac disease. The conundrum of unveiling the dark side of the moon.

2025

European journal of internal medicine

Corazza GR, Lenti MV

PubMed

A comparative study of different assays for autoantibodies detection in patients with autoimmune gastritis.

2025

Journal of translational autoimmunity

Osmola M, Hémont C, Romańczyk M, Druet A, Chapelle N +3 more

Plain English
This study looked at how well different tests can detect specific antibodies in patients with autoimmune gastritis (AIG), a condition that can lead to stomach cancer. Researchers tested 50 patients with AIG and 93 healthy individuals, finding that a specific type of test called the fluorescent enzyme immunoassay (FEIA) was the most accurate for detecting antibodies related to AIG, with a specificity of 100% and a detection sensitivity that improved to 50% with adjustments. Importantly, when testing for both types of antibodies together, the sensitivity increased to 90%, which could help in early detection and treatment of AIG. Who this helps: This benefits patients with autoimmune gastritis by improving how quickly and accurately their condition can be diagnosed.

PubMed

The influence ofinfection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway.

2025

Frontiers in immunology

De Re V, Casarotto M, Brisotto G, Zanussi S, De Zorzi M +11 more

Plain English
This study looked at how different strains of the bacteria H. pylori affect the effectiveness of a cancer drug called trastuzumab in treating HER2-positive gastric cancer. Researchers found that a highly virulent strain of H. pylori decreased the levels of important genes for DNA repair and increased immunosuppressive signals in cancer cells, which could make them less responsive to treatment. This is significant because it suggests that infections may influence how well cancer treatments work, potentially leading to poorer outcomes for patients. Who this helps: This helps patients with HER2-positive gastric cancer by highlighting the importance of managing infections during treatment.

PubMed

Vitamin B12 in Cancer Patients: Clinical Insights into Deficiency, Excess, Diagnosis, and Management.

2025

Nutrients

Osmola M, Tyszka M, Jirka A, Ciepiela O, Kapała A +2 more

Plain English
This study looked at how vitamin B12 affects cancer patients, particularly focusing on its deficiency and excess. It found that vitamin B12 deficiency is a significant issue, potentially causing anemia in up to 60% of cancer patients, with rates of deficiency ranging from 6% to 48%, especially among older patients and those with gastrointestinal cancers. Addressing vitamin B12 levels can help manage symptoms related to chemotherapy, making it essential for improving patient care. Who this helps: This helps cancer patients and their healthcare providers.

PubMed

European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective.

2025

United European gastroenterology journal

Lenti MV, Hammer HF, Tacheci I, Burgos R, Schneider S +25 more

Plain English
This study focuses on malabsorption, a condition where nutrients are not properly absorbed into the body, affecting both children and adults. It highlights the importance of recognizing malabsorption early and identifying its causes, often through various medical tests, especially in people at high risk, like those with coeliac disease. Nutritional support is vital for managing malabsorption, with options ranging from oral supplements to therapies that reduce the need for intravenous feeding in severe cases. Who this helps: This benefits patients with malabsorption conditions, doctors, and healthcare providers.

PubMed

European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption.

2025

United European gastroenterology journal

Lenti MV, Hammer HF, Tacheci I, Burgos R, Schneider S +25 more

Plain English
This study discusses malabsorption, which occurs when the body struggles to absorb nutrients properly, affecting both children and adults. The consensus identified conditions that lead to malabsorption, like cystic fibrosis and coeliac disease, and emphasized the importance of early diagnosis through medical history and various tests; for example, 60% of malabsorption cases are linked to coeliac disease in patients with no apparent cause. Understanding malabsorption better helps healthcare providers create tailored treatment plans, improving patients' health outcomes. Who this helps: Patients with malabsorption disorders.

PubMed

A step forward for improving the endoscopic diagnosis of autoimmune gastritis.

2025

Endoscopy

Lenti MV, Di Sabatino A

PubMed

Rethinking the Use of Biologics in Inflammatory Bowel Disease Patients With Malignancy: Insights From the Treatment of Immune Checkpoint Inhibitor-Induced Colitis.

2025

Inflammatory bowel diseases

Lenti MV, Santacroce G, Di Sabatino A

PubMed

Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease.

2025

Science translational medicine

Singh M, Louie RHY, Samir J, Field MA, Milthorpe C +26 more

Plain English
This study looked at patients suffering from a severe form of celiac disease that doesn't improve with a gluten-free diet. Researchers found that in certain patients, immune cells called T cells had mutations linked to lymphoma, with 6 out of 10 patients showing these changes. This matters because it helps explain why some patients don’t respond to treatment and may lead to better understanding or management of their condition. Who this helps: This helps patients with refractory celiac disease and their doctors.

PubMed

Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study.

2025

Clinical and translational gastroenterology

Lahner E, Annibale B, Dilaghi E, Luciano Millado C, Lenti MV +25 more

Plain English
This study examined two types of atrophic gastritis—multifocal (MF-AG) and corpus-restricted (CR-AG)—in patients who also had non-cardia gastric cancer (GC) or precancerous changes (dysplasia). Out of 84 patients, 56% had cancer, with similar rates observed in both types of atrophic gastritis. However, the cancer tended to appear more often as polyp-like growths in CR-AG patients, leading to more frequent surgeries compared to those with MF-AG. Who this helps: This research benefits doctors managing patients at risk for gastric cancer.

PubMed

Clinical Heterogeneity of Early-Onset Autoimmune Gastritis: From the Evidence to a Pediatric Tailored Algorithm.

2025

Diseases (Basel, Switzerland)

Taietti I, Votto M, Castagnoli R, Bertozzi M, De Filippo M +7 more

Plain English
This study looked at autoimmune gastritis in children, a rare condition that causes stomach inflammation and can lead to serious health issues like anemia and an increased risk of stomach cancer. Two case studies were presented, including a 9-year-old girl with difficult-to-treat anemia and a 12-year-old boy initially misdiagnosed with another condition. The research emphasizes the need for doctors to consider autoimmune gastritis in children with ongoing stomach problems and the importance of proper diagnosis to prevent long-term complications. Who this helps: This research benefits doctors who treat children with gastrointestinal symptoms.

PubMed

Challenges in the diagnosis of coeliac disease in primary care: Serology, biopsy, and administrative data.

2025

European journal of internal medicine

Lenti MV, Santacroce G, Di Sabatino A

PubMed

Empowering the vulnerable in internal medicine: a narrative review on physical exercise as a tool to tackle frailty.

2025

Internal and emergency medicine

Lenti MV, Brera AS, Di Sabatino A, Corazza GR

Plain English
This study looked at frailty, a condition often seen in older adults that leads to weakness and fatigue, making them more likely to get sick or die. Researchers found that regular physical exercise can help reduce or even reverse frailty, which is important because frail patients tend to have higher rates of hospitalization. By encouraging exercise, we can help older adults maintain their health and independence longer. Who this helps: This benefits older patients at risk for frailty and their healthcare providers.

PubMed

Letter to the Editor.

2025

The American journal of gastroenterology

Lenti MV, Miceli E, Camargo MC, Di Sabatino A

PubMed

Correlates of Polypharmacy and Prescription Changes in Internal Medicine: a Prospective Five-Year Study.

2025

The American journal of medicine

Lenti MV, Frenna C, Brera AS, Di Sabatino A, Klersy C +1 more

Plain English
This study looked at the use of multiple medications (called polypharmacy) in older patients at a hospital over five years. It found that 71.5% of patients were taking many medications when they were admitted, and this increased to 82.6% by the time they were discharged. The study revealed that older, frail patients with multiple health issues were more likely to be on many medications, which is linked to a higher chance of dying, highlighting the need for better ways to manage their medications. Who this helps: This helps patients and doctors by emphasizing the importance of careful medication management for older adults.

PubMed

Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study.

2025

European annals of allergy and clinical immunology

Rossi CM, Merli S, Lenti MV, De Amici M, di Sabatino A

Plain English
This study looked at patients with wheat allergy who also experience hives, a condition known as WALDA. Among the 11 patients studied, 73% had other allergic conditions like food or respiratory allergies, and 73% were also allergic to shrimp. This research is important because it helps doctors better understand the characteristics of patients with WALDA, enabling more effective diagnosis and treatment. Who this helps: This helps patients with wheat allergies, especially those who experience hives.

PubMed

Mechanistic Gaps in Linking Aero- and Food Allergens to Irritable Bowel Syndrome.

2025

Neurogastroenterology and motility

Rossi CM, Lenti MV, Di Sabatino A

PubMed

Disrupted mucosal vascular barrier in eosinophilic esophagitis.

2025

Scientific reports

Lenti MV, Rossi CM, Cannizzaro R, Santacroce G, Lizier M +13 more

Plain English
This study focused on how the blood vessels in the esophagus are affected in patients with eosinophilic esophagitis (EoE), a condition where the immune system causes inflammation in the esophagus. Researchers found that, in EoE patients, blood vessel barriers were leaking, while this was not the case in patients with reflux esophagitis or healthy individuals. In fact, levels of a specific marker for blood vessel integrity were significantly higher in EoE patients, showing that an active form of this condition disrupts the esophageal vascular barrier. Who this helps: This information benefits patients with eosinophilic esophagitis and their doctors in understanding the condition better.

PubMed

Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study.

2025

Frontiers in immunology

Massironi S, Dispinzieri G, Rossi A, Cristoferi L, Lenti MV +7 more

Plain English
This study looked at how autoimmune gastritis (AIG) and autoimmune liver diseases (AILDs) often overlap in patients. Researchers found that 22.1% of patients with AILD tested positive for a specific antibody linked to AIG, with a median diagnosis age of 58. Among these positive cases, 91.3% were confirmed to have AIG, and many also had other autoimmune conditions like thyroiditis. Who this helps: This research benefits patients with autoimmune liver diseases by promoting earlier diagnosis and better management of related gastric issues.

PubMed

Pediatric autoimmune gastritis: An international, multicentric study.

2025

Journal of pediatric gastroenterology and nutrition

Lenti MV, Joudaki S, Miceli E, Lahner E, Massironi S +36 more

Plain English
This study looked at how autoimmune gastritis (AIG) manifests in children under 18 years old. The researchers reviewed data from 51 patients and found that 92% had the most serious form of AIG, with a variety of related conditions like atopic dermatitis and asthma observed in some patients. Most notably, only one child had a Helicobacter pylori infection, which is often linked to stomach issues, suggesting a different cause for AIG in kids. Who this helps: This information benefits pediatricians and healthcare providers by improving understanding and diagnosis of AIG in young patients.

PubMed

Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary study.

2025

Journal of multimorbidity and comorbidity

Lenti MV, Brera AS, Broglio G, Bertolino G, Di Sabatino A +2 more

Plain English
This study looked at the presence of other health issues (comorbidities) in patients with inflammatory bowel disease (IBD) who were either hospitalized or not. Out of 104 patients, 60.6% had comorbidities, with hospitalized patients being more affected (66.6% vs. 58.5% for outpatients). Factors like being older than 65, being female, having low income, and lower education levels were linked to higher chances of having multiple health issues, highlighting the need for targeted support for these patients. Who this helps: This helps patients with IBD, particularly older individuals, women, and those with lower socioeconomic status.

PubMed

Response to Shangguan and Tan.

2025

The American journal of gastroenterology

Lenti MV, Miceli E, Di Sabatino A

PubMed

Commentary: Towards multi-targeting approaches in intestinal fibrosis - Emerging clues from prim-O-glucosylcimifugin.

2025

Life sciences

Santacroce G, Lenti MV, Lo Bello A, Di Sabatino A

PubMed

A Novel Tool for Celiac Disease Classification Based on Clinical, Immunological and Genetic Markers.

2025

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Pala D, Naidu K, Lenti MV, Di Sabatino A, Nicora G

Plain English
This study looked at a new tool designed to classify patients with Celiac Disease (CD) using various health markers, including symptoms, immune responses, and genetics. The researchers evaluated the tool on a group of nearly 2,500 patients and found it can effectively identify different subtypes of CD, which is crucial for timely treatment and avoiding serious health issues. Early and accurate classification can help prevent complications that arise from untreated CD, making it important for patient care. Who this helps: This benefits patients with Celiac Disease and their doctors by improving diagnosis and treatment strategies.

PubMed

HER2, HER3, and Mismatch Repair Protein Expression in Stage IV Small Bowel Adenocarcinoma: Results From a Multicenter Series.

2025

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Vanoli A, Colella T, Parente P, De Lisi G, Grillo F +16 more

Plain English
This study looked at a rare form of cancer called stage IV small bowel adenocarcinoma (SBA) to see how certain proteins related to cancer treatment were expressed. They found that 11.5% of the tumors had a mismatch repair deficiency, 7.7% tested positive for HER2, and 40% had HER3 positivity, showing some differences in how these proteins appeared across tumors. These results are important because they highlight the need to check these biomarkers in SBA patients to improve treatment options, especially since there were differences between the primary tumors and their metastases. Who this helps: Patients with stage IV small bowel adenocarcinoma.

PubMed

Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centre.

2025

Internal and emergency medicine

Lenti MV, Santacroce G, Lepore F, Mordà F, Lo Bello A +6 more

Plain English
This study looked at how long patients with inflammatory bowel disease (IBD) stick with their first-line advanced therapies, such as biologics and oral medications. Out of 274 patients observed, half (51.5%) continued their treatment, while 26% stopped due to ineffectiveness. The findings suggest that the type of Crohn's disease a patient has, how long they had the disease before starting therapy, and whether they also used certain medications can affect their likelihood of sticking with treatment. Who this helps: This benefits patients with inflammatory bowel disease by highlighting the factors that can improve their treatment success.

PubMed

Effect of seasonal exposure in aeroallergen-sensitised patients with irritable bowel syndrome-diarrhoea.

2025

Frontiers in allergy

Rossi CM, Lenti MV, Merli S, Fiorita M, Lo Bello A +5 more

Plain English
This study looked at how pollen allergies affect people with irritable bowel syndrome that causes diarrhea (IBS-D). Researchers analyzed data from 61 IBS patients over a period of time and found that those allergic to grass experienced a worsening of their gastrointestinal symptoms during pollen season, with a significant increase in their symptom scores by an average of 3.4 points. This is important because it shows that seasonal allergies can make IBS-D symptoms worse, which can help in managing treatment for these patients. Who this helps: Patients with IBS-D who have grass pollen allergies.

PubMed

Latent class analysis identifies novel coeliac disease subgroups with distinctive clinical features: a multicentric study.

2025

European journal of internal medicine

Lenti MV, Pala D, Aronico N, Dagliati A, Bianchi PI +6 more

Plain English
This study looked at different types of coeliac disease (CD) by analyzing the symptoms and clinical characteristics of 2,478 adult patients from 19 centers in Italy. Researchers identified four distinct subgroups of CD patients: those with mainly lower gastrointestinal symptoms, those with upper gastrointestinal issues, those who are mostly asymptomatic, and those with anemia and fatigue. They found that some patients might be misclassified under traditional criteria, suggesting that personalized approaches could improve diagnosis and treatment for CD. Who this helps: This benefits patients with coeliac disease by potentially leading to better diagnosis and tailored treatments for their specific symptoms.

PubMed

Different Survival Outcomes of Small Bowel Adenocarcinomas and T-Cell Lymphomas Associated With Celiac Disease.

2025

The American journal of gastroenterology

Santacroce G, Vanoli A, Aronico N, Bianchi PI, Lenti MV +11 more

Plain English
This study looked at two types of serious cancers linked to celiac disease: small bowel adenocarcinoma (SBA) and T-cell lymphoma (TCL). Researchers found that patients with SBA had a much better chance of surviving than those with TCL, with survival rates significantly different between the two groups. Specifically, 70% of TCL patients did not respond to a gluten-free diet, while only one patient with SBA did not benefit from it. This research highlights the need for different approaches in treating these two cancer types. Who this helps: This helps doctors and patients dealing with celiac disease and its associated cancers.

PubMed

A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting.

2025

European journal of gastroenterology & hepatology

Scalvini D, Bezzio C, Maimaris S, Lenti MV, Francesca L +18 more

Plain English
In this study, researchers compared two types of bowel preparation methods, 1L-PEG-ASC and 2L-PEG, for patients with inflammatory bowel disease (IBD) undergoing outpatient colonoscopy. They found that 1L-PEG-ASC was more effective, with 89.8% of patients achieving adequate preparation compared to 83.8% with 2L-PEG. Additionally, factors like being male, having a history of specific surgeries, and having stricturing Crohn’s disease were linked to poorer preparation results. Who this helps: This benefits patients with IBD who need effective bowel preparation before a colonoscopy.

PubMed

Pinworm Infection Misdiagnosed With Primary Eosinophilic Colitis. A Case Series.

2024

ACG case reports journal

Rossi CM, Lenti MV, Lo Bello A, Merli S, Vanoli A +2 more

Plain English
This study looked at three patients who were incorrectly diagnosed with a type of gastrointestinal disorder called primary eosinophilic gastrointestinal disorders (EGID) when they actually had pinworm infections. The researchers found that these pinworm infections were overlooked, leading to confusion in their treatment. This is important because it shows that doctors need to consider parasitic infections when diagnosing gastrointestinal issues, especially since misdiagnosis can complicate patient care. Who this helps: This helps doctors and patients dealing with gastrointestinal disorders.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.